Hyderabad Telangana, India

Ramarao Dodda

This inventor holds 1 USPTO granted patent. Top assignee: Mylan Laboratories Limited. Active years: 2018.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ramarao Dodda: Innovator in Pharmaceutical Chemistry

Introduction

Ramarao Dodda is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug preparation. His work has implications for the treatment of various medical conditions, showcasing his commitment to advancing healthcare through scientific innovation.

Latest Patents

Ramarao Dodda holds a patent for a process related to the preparation of empagliflozin. This patent, titled "Process for the preparation of empagliflozin," discloses an improved method for synthesizing this important pharmaceutical compound. The patent also introduces novel intermediates of formulas (13) and (14) for the preparation of empagliflozin, wherein Rand Rare independently hydrogen or hydroxyl protecting groups. This innovation is crucial for enhancing the efficiency and effectiveness of empagliflozin production.

Career Highlights

Ramarao Dodda is currently employed at Mylan Laboratories Limited, a leading global pharmaceutical company. His role at Mylan allows him to apply his expertise in pharmaceutical chemistry to develop new and improved medications. His dedication to research and development has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Ramarao has collaborated with talented professionals, including Vipin Kumar Kaushik and Jagan Mohana Chary Tummanepally. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of new pharmaceutical processes.

Conclusion

Ramarao Dodda's contributions to pharmaceutical chemistry, particularly through his patent for empagliflozin, highlight his role as an innovator in the field. His work at Mylan Laboratories Limited and collaborations with other professionals further emphasize his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…